{
    "title": "ADC Therapeutics pauses enrollment in cancer drug trial after patient deaths",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12286759/ADC-Therapeutics-pauses-enrolment-mid-stage-trial-cancer-therapy.html",
    "date": "2023-07-11",
    "keywords": [
        "drug",
        "trial",
        "study",
        "raghav",
        "mahobe",
        "midstage",
        "cancer",
        "respiratory",
        "zynlonta",
        "rituximab",
        "bcell",
        "company",
        "adc",
        "approval",
        "july",
        "type",
        "blood",
        "drugmaker",
        "review",
        "antibody",
        "rituxan",
        "diffuse",
        "investigator",
        "assessment",
        "cause",
        "edema",
        "covid19",
        "infection",
        "analyst",
        "boris",
        "peaker",
        "note",
        "safety",
        "combination",
        "change",
        "protocol",
        "dose",
        "exclusion",
        "food",
        "administration",
        "lymphoma",
        "treatment",
        "confirmatory",
        "end",
        "year",
        "europe",
        "decision",
        "enrollment",
        "reporting",
        "bengaluru",
        "editing",
        "kalluvila",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}